Vericel director receives RSUs, options grants
Vericel Corp director Heidi Hagen reported routine equity compensation activity.
Rhea-AI Filing Summary
Vericel Corp director Heidi Hagen reported routine equity compensation activity. She exercised 3,200 Restricted Stock Units into 3,200 shares of common stock, bringing her direct common stock holdings to 35,050 shares. She also received a new grant of 3,200 RSUs that vest 100% on the earlier of April 29, 2027 or the first Annual Meeting of Stockholders following April 29, 2026. In addition, she was granted stock options for 8,000 shares at an exercise price of $33.43 per share, vesting in equal monthly increments over one year and expiring on April 29, 2036. All transactions reflect awards and exercises rather than open‑market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,200 shares exercised/converted
Exercise
4 txns
Insider
Hagen Heidi
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 3,200 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 8,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 3,200 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,200 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 8,000 contracts (Direct);
Restricted Stock Unit — 3,200 contracts (Direct);
Common Stock — 35,050 shares (Direct)
Footnotes (6)
- F1. The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 30, 2025.
- F2. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
- F3. These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.
- F4. No expiration date for this type of award.
- F5. The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
- F6. These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.
Key Figures
RSUs exercised: 3,200 shares
Common stock holdings: 35,050 shares
New RSU grant: 3,200 RSUs
+3 more
6 metrics
RSUs exercised
3,200 shares
Restricted Stock Units converted to common stock on April 29, 2026
Common stock holdings
35,050 shares
Direct Vericel common stock owned after transactions
New RSU grant
3,200 RSUs
Vest 100% on earlier of April 29, 2027 or first Annual Meeting after April 29, 2026
Stock options granted
8,000 options
Right to buy Vericel common stock granted April 29, 2026
Option exercise price
$33.43 per share
Conversion or exercise price for 8,000 stock options
Option expiration
April 29, 2036
Scheduled expiration date of granted stock options
Key Terms
Restricted Stock Unit, RSU, Stock Option (Right to Buy), Annual Meeting of Stockholders, +1 more
5 terms
Restricted Stock Unit financial
"The shares of common stock were acquired ... as a result of the vesting of Restricted Stock Units (RSUs) granted..."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
RSU financial
"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" with 8,000.0000 derivative shares granted."
Annual Meeting of Stockholders financial
"These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders..."
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security" for RSU vesting and option-related activity."
FAQ
What insider transactions did Vericel (VCEL) director Heidi Hagen report?
Heidi Hagen reported equity compensation activity, including exercising 3,200 RSUs into common stock and receiving new grants of 3,200 RSUs and 8,000 stock options. These are awards and exercises, not open‑market share purchases or sales.
What are the terms of Heidi Hagen’s new Vericel (VCEL) RSU grant?
Hagen received 3,200 Restricted Stock Units, each representing one Vericel common share. These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026, subject to continued service.
What are the key details of the stock options granted to Heidi Hagen at Vericel (VCEL)?
Hagen was granted stock options covering 8,000 Vericel common shares at an exercise price of $33.43 per share. The options vest over one year in equal monthly increments, contingent on continued service, and are scheduled to expire on April 29, 2036.
AI-generated analysis. How Rhea-AI works. Not financial advice.
